NYSE - Delayed Quote • USD
American Well Corporation (AMWL)
At close: May 17 at 4:00 PM EDT
After hours: May 17 at 7:35 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 9 | 8 |
| Avg. Estimate | -0.2 | -0.19 | -0.82 | -0.49 |
| Low Estimate | -0.23 | -0.21 | -0.9 | -0.61 |
| High Estimate | -0.17 | -0.16 | -0.76 | -0.35 |
| Year Ago EPS | -0.33 | -0.48 | -2.38 | -0.82 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 10 | 10 | 11 | 11 |
| Avg. Estimate | 61.71M | 64.5M | 261.67M | 322.49M |
| Low Estimate | 59.3M | 62.18M | 259.06M | 287.3M |
| High Estimate | 64.16M | 68.04M | 264.03M | 343.39M |
| Year Ago Sales | 62.45M | 61.92M | 259.05M | 261.67M |
| Sales Growth (year/est) | -1.20% | 4.20% | 1.00% | 23.20% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.22 | -0.21 | -0.2 | -0.19 |
| EPS Actual | -0.33 | -0.48 | -0.17 | -0.25 |
| Difference | -0.11 | -0.27 | 0.03 | -0.06 |
| Surprise % | -50.00% | -128.60% | 15.00% | -31.60% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.2 | -0.19 | -0.82 | -0.49 |
| 7 Days Ago | -0.19 | -0.18 | -0.79 | -0.49 |
| 30 Days Ago | -0.19 | -0.19 | -0.75 | -0.46 |
| 60 Days Ago | -0.18 | -0.18 | -0.74 | -0.43 |
| 90 Days Ago | -0.18 | -0.18 | -0.72 | -0.51 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 3 | 4 | 3 | 5 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | 1 | 1 | 1 |
Growth Estimates
| CURRENCY IN USD | AMWL | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 39.40% | -- | -- | 8.00% |
| Next Qtr. | 60.40% | -- | -- | 12.40% |
| Current Year | 65.50% | -- | -- | 5.60% |
| Next Year | 40.20% | -- | -- | 13.00% |
| Next 5 Years (per annum) | 37.90% | -- | -- | 11.14% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | Needham: Hold | 5/2/2024 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 4/15/2024 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 11/2/2023 |
| Downgrade | Morgan Stanley: Overweight to Equal-Weight | 8/3/2023 |
| Maintains | Credit Suisse: Neutral | 5/4/2023 |
| Downgrade | TD Cowen: Outperform to Market Perform | 3/23/2023 |
Related Tickers
TDOC Teladoc Health, Inc.
12.73
-1.32%
GDRX GoodRx Holdings, Inc.
7.48
-7.20%
TALK Talkspace, Inc.
2.7500
-1.79%
TXG 10x Genomics, Inc.
25.01
-2.27%
SHCR Sharecare, Inc.
0.8558
+9.12%
MPLN MultiPlan Corporation
0.5893
-1.36%
DOCS Doximity, Inc.
28.03
+18.07%
ACCD Accolade, Inc.
7.48
+2.05%
PGNY Progyny, Inc.
28.09
+1.96%
AUGX Augmedix, Inc.
1.2100
-1.63%